Glyxambi 5 mg/1

Glyxambi 5 mg/1 combines empagliflozin and linagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Glyxambi 5 mg/1 is used to help manage type 2 diabetes in adults. It combines two active ingredients, empagliflozin and linagliptin, to support blood sugar control. This medication is typically used alongside diet and exercise to improve glycemic control. It is not intended for type 1 diabetes or diabetic ketoacidosis.

Common effects of Glyxambi 5 mg/1 may include urinary tract infections, hypoglycemia, and upper respiratory tract infections. Some users may experience dizziness or headache. Individual responses can vary, and not everyone will experience these effects.

Glyxambi 5 mg/1 should be stored at room temperature, away from moisture and heat. Keep this medication out of reach of children. Always follow the guidance of a healthcare provider regarding its use, especially if you have a history of kidney issues or pancreatitis.

Glyxambi 5 mg/1 may interact with certain medications, including insulin, other diabetes drugs, and diuretics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider.